IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.
Item Statistics
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease
Repository | University of Queensland [UQ eSpace] |
URL | https://espace.library.uq.edu.au/view/UQ:220957 |
Author(s) | Meissner, H.C.; Groothuis, J.R.; Rodriguez, W.J.; Welliver, R.C.; Hogg, G.; Gray, P.H.; Loh, R.; Simoes, E.A.F.; Sly, P.; Miller, A.K.; Nichols, A.I.; Jorkasky, D.K.; Everitt, D.E.; Thompson, K.A. |
Item type | Article |
Journal | Antimicrobial Agents and Chemotherapy, Print_ISSN:0066-4804, Online_ISSN:1098-6596 |